GENERICally Speaking Hatch Waxman Bulletin

The Hatch-Waxman Litigation practice group at Robins Kaplan LLP is pleased to offer the latest edition of their quarterly publication regarding ANDA patent litigation issues and the generics business.

Vol. 2, No. 1

Spring 2012

Relevant court decisions highlighted in this issue:

  • Mayo Collaborative Servs. v. Prometheus Labs., Inc.
  • Sciele Pharma. Inc. v. Lupin Ltd.
  • AstraZeneca Pharma. LP v. Apotex Corp.


Oren D. Langer


Managing Partner, New York Office
Member of Executive Board

Ryan M. Schultz


Pronouns: he/him

Reference Listed Drug, NDA Holder, Generic Drug Name, ANDA Applicant(s), Indication and Launch Date

Vol. 2, No. 2

Summer 2012

Vol. 2, No. 3

Fall 2012

Vol. 2, No. 4

Winter 2012